Antimalarial Medication Can Reduce Inflammation in SLE Patients, Study Shows
Hydroxychloroquine, an antimalarial medication, can help normalize levels of an immune molecule that promotes inflammation in patients with systemic lupus erythematosus, a study shows. The study, “Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers,” was published in the journal Inflammopharmacology. Systemic lupus…